Drug Profile
Research programme: thrombin inhibitor - Afid Therapeutics
Alternative Names: Heparin replacementLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Afid Therapeutics
- Class Carbohydrates
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Thrombosis in USA
- 19 Aug 2008 Preclinical trials in Thrombosis in USA (Unspecified)